Leon Bergfeld
Overview
Explore the profile of Leon Bergfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sorg A, Bergfeld L, Jank M, Corman V, Semmler I, Goertz A, et al.
Nat Commun
. 2022 Jun;
13(1):3128.
PMID: 35668073
The rate of SARS-CoV-2 infections in children remains unclear due to many asymptomatic cases. We present a study of cross-sectional seroprevalence surveys of anti-SARS-CoV-2 IgG in 10,358 children recruited in...
2.
Schneider J, Bachmann F, Choi M, Kurvits L, Schmidt M, Bergfeld L, et al.
Transbound Emerg Dis
. 2021 Dec;
69(2):221-226.
PMID: 34850584
West Nile Virus (WNV) infections are increasingly detected in birds and horses in central Europe, with the first mosquito-borne autochthonous human infection detected in Germany in 2019. Human infections are...
3.
Wlodarczyk E, Viklicky O, Budde K, Kolarova M, Bergfeld L, Paczek L, et al.
Int J Environ Res Public Health
. 2021 Oct;
18(19).
PMID: 34639582
Despite an increasing quality of life after renal transplantation, the number of recipients undertaking paid professional work remains relatively low. Employment after kidney transplantation became a new important marker of...
4.
Schwaiger E, Krenn S, Kurnikowski A, Bergfeld L, Perez-Saez M, Frey A, et al.
J Am Soc Nephrol
. 2021 Jul;
32(8):2083-2098.
PMID: 34330770
Background: Post-transplantation diabetes mellitus (PTDM) might be preventable. Methods: This open-label, multicenter randomized trial compared 133 kidney transplant recipients given intermediate-acting insulin isophane for postoperative afternoon glucose ≥140 mg/dl with...
5.
Schrezenmeier E, Bergfeld L, Hillus D, Lippert J, Weber U, Tober-Lau P, et al.
Front Immunol
. 2021 Jul;
12:690698.
PMID: 34276681
Patients with kidney failure have notoriously weak responses to common vaccines. Thus, immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine immunogenicity of SARS-CoV-2 vaccination in...
6.
Tober-Lau P, Schwarz T, Hillus D, Spieckermann J, Helbig E, Lippert L, et al.
Emerg Infect Dis
. 2021 Jun;
27(8):2169-2173.
PMID: 34102098
One week after second vaccinations were administered, an outbreak of B.1.1.7 lineage severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility in Berlin, Germany, affecting 16/20...
7.
Schwarz T, Tober-Lau P, Hillus D, Helbig E, Lippert L, Thibeault C, et al.
Emerg Infect Dis
. 2021 Jun;
27(8):2174-2178.
PMID: 34102097
We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (median age 34 years) in...
8.
Duerr M, Schrezenmeier E, Lehner L, Bergfeld L, Glander P, Marticorena Garcia S, et al.
BMC Nephrol
. 2019 Feb;
20(1):36.
PMID: 30717681
Background: Only a few prospective trials exist regarding the use of novel direct-acting antiviral agents (DAAs) in kidney transplant recipients (KTR) with chronic hepatitis C virus (HCV) infection. Methods: This...
9.
Bergfeld L, Werzowa J, Saemann M, Hecking M
Transpl Int
. 2018 Jan;
31(4):456-457.
PMID: 29377325
No abstract available.